P - Cautioned while taken during pregnancy
L - Cautioned while taken during lactation
Betahistine hydrochloride is the generic name for the anti vertigo drug SERC. It was first registered in Europe in 1970 for the treatment of Ménière's disease. It is commonly prescribed for people who have balance disorders or to alleviate the vertigo symptoms associated with Ménière's disease.
Betahistine is available in 8mg, 16mg, or 24mg tablets. It is contraindicated for people with peptic ulcers or tumours of the adrenal gland. People with bronchial asthma should be closely monitored.
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
Absorption: Rapid and complete.
Metabolism: Hepatic.
Excretion: Urine (as inactive metabolites); 3.4 hr (elimination half-life).
Information Not Available
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia
Information Not Available
Active peptic ulcer, bronchial asthma, pregnancy and lactation
May antagonise antihistamines. May decrease bronchodilator effects of β-2 agonists.
Information Not Available
Oral
Meniere's disease
Adult: Initially, 16 mg tid. Maintenance: 24-48 mg daily
Should be taken with food
Caution when used during pregnancy
Caution when used during lactation
Information Not Available
Information Not Available
Phaeochromocytoma. Porphyria
Oral: Store below 25°C
Oral: Store below 25°C
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.